drugset / Trial / NCT00734656
Pharmacogenetics of Alcohol: Treatment Implications
Completed
94 enrolled
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabNational Institutes of Health (NIH) · collab
RandomizedFactorialQuadruple-blind
Summary
This study will explore the hypothesis that effects of alcohol are in part mediated by increased production of neuroactive steroids, which interact with GABAA-receptors. We propose to study non-dependent drinkers using a 4-session within-subjects design in which alcohol / placebo is paired with dutasteride / placebo pretreatment. Dutasteride is a 5-alpha steroid reductase (5AR) inhibitor that limits the production of dihydrotestosterone and the 5a-reduced neuroactive steroids allopregnanolone, pregnanolone and 3a,5a-androstanediol.
Timeline
- Start
- 2007-03
- Primary completion
- 2010-10
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcohol | Other / unclassified | 0.8 mg/kg | — |
| Subject | Alcohol | Other / unclassified | 1 ml | — |
| Subject | Dutasteride | Small molecule | 4 mg | — |